CD34 immunoreactivity distinguishes between scar tissue and residual tumor in re‐excisional specimens of dermatofibrosarcoma protuberans
Authors:
- 1 August 1994
- journal article
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 21 (4) , 324-329
Abstract
Dermatofibrosarcoma protuberans (DFSP) is a locally aggressive tumor that often recurs after simple excision, and therefore usually requires wide surgical re‐excision. It is sometimes difficult to distinguish histologically between residual tumor and scar tissue formed in response to the original biopsy. In an effort to solve this diagnostic problem, we have examined CD34 immunoreactivity in 10 primary biopsies of DFSP, 12 scars, and 7 re‐excisional DFSP specimens containing residual tumor adjacent to scar tissue. In all 10 primary biopsies of DFSP, the tumor cells strongly and uniformly expressed CD34. In the 12 scars, only periaclnexal cells, enclothclial cells, and rare, scattered dendritic cells in the clermis were immunolabeled for CD34. In the 7 re‐excisions of DFSP, the foci of residual DFSP were strongly immunolabeled, while the surrounding scar tissue was not. The pattern of CD34 immunoreactivity distinguishes DFSP from scar tissue, and thereby may permit more accurate assessment of surgical margins in re‐excisional specimens of DFSP.Keywords
This publication has 14 references indexed in Scilit:
- CD-34 Is Expressed by a Distinctive Cell Population in Peripheral Nerve, Nerve Sheath Tumors, and Related LesionsAmerican Journal of Surgical Pathology, 1993
- Expression of the human progenitor cell antigen CD34 (HPCA-1) distinguishes dermatofibrosarcoma protuberans from fibrous histiocytoma in formalin-fixed, paraffin-embedded tissueJournal of the American Academy of Dermatology, 1993
- Expression of the human hematopoietic progenitor cell antigen CD34 in vascular and spindle cell tumorsJournal of Cutaneous Pathology, 1993
- Dermatofibrosarcoma protuberans is a unique fibrohistiocytic tumour expressing CD34British Journal of Dermatology, 1992
- The Human Hematopoietic Progenitor Cell Antigen (CD 3 4) in Vascular NeoplasiaAmerican Journal of Clinical Pathology, 1991
- QBEND/10, a new monoclonal antibody to endothelium: assessment of its diagnostic utility in paraffin sectionsHistopathology, 1990
- Expression of the CD34 gene in vascular endothelial cellsBlood, 1990
- Dermatofibrosarcoma Protuberans in a 9‐Year‐Old Child: Treatment by MOHS Micrographic SurgeryPediatric Dermatology, 1990
- Treatment of Dermatofibrosarcoma Protuberans with Mohs Micrographic SurgeryAnnals of Surgery, 1988
- Dermatofibrosarcoma protuberans.A study of 115 casesCancer, 1962